Pharma Journalist

Developments in Protein Engineering An interview with panelist: Maria Lucas, CEO, Zymvol

By Pharma Journalist on September 14, 2021

Related Posts

2nd T-Cell Engager for Autoimmune Disease Summit Returns in 2026 to Advance the Next Wave of Autoimmune Therapeutics

New Era for Autoimmune T-Cell Engagers Takes Centre Stage This October

From Innovation to Acquisition: CrossBridge Bio’s ADC Journey

COPD Foundations Joins the COPD Drug Development Summit

Lonza Secures Nona’s BBB Technology for CNS Drug Development

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th Annual Meeting
Comments (0)
Add Comment